Brief: Mustang Bio Says On Nov 22, Notified By Nasdaq That Nasdaq Had Granted Co's Request To Transfer Listing Of Co's Common Stock To Nasdaq Capital Market Tier
Nov 25 (Reuters) - Mustang Bio Inc MBIO.O :
* MUSTANG BIO - ON NOV 22, NOTIFIED BY NASDAQ THAT NASDAQ
HAD
GRANTED CO'S REQUEST TO TRANSFER LISTING OF CO'S COMMON STOCK TO
NASDAQ CAPITAL MARKET TIER
* MUSTANG BIO INC - NASDAQ ALSO GRANTED CO'S REQUEST FOR A
SECOND
180-CALENDAR DAY PERIOD TO REGAIN COMPLIANCE WITH $1.00 BID
PRICE REQUIREMENT
Further company coverage: MBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie